|
1
|
Yamane K, Toumazou C, Tsukada Y,
Erdjument-Bromage H, Tempst P, Wong J and Zhang Y: JHDM2A, a
JmjC-containing H3K9 demethylase, facilitates transcription
activation by androgen receptor. Cell. 125:483–495. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kooistra SM and Helin K: Molecular
mechanisms and potential functions of histone demethylases. Nat Rev
Mol Cell Biol. 13:297–311. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Knebel J, De Haro L and Janknecht R:
Repression of transcription by TSGA/Jmjd1a, a novel interaction
partner of the ETS protein ER71. J Cell Biochem. 99:319–329. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lockman K, Taylor JM and Mack CP: The
histone demethylase, Jmjd1a, interacts with the myocardin factors
to regulate SMC differentiation marker gene expression. Circ Res.
101:e115–e123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fan L, Peng G, Sahgal N, Fazli L, Gleave
M, Zhang Y, Hussain A and Qi J: Regulation of c-Myc expression by
the histone demethylase JMJD1A is essential for prostate cancer
cell growth and survival. Oncogene. 35:2441–2452. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tee AE, Ling D, Nelson C, Atmadibrata B,
Dinger ME, Xu N, Mizukami T, Liu PY, Liu B, Cheung B, et al: The
histone demethylase JMJD1A induces cell migration and invasion by
up-regulating the expression of the long noncoding RNA MALAT1.
Oncotarget. 5:1793–1804. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sechler M, Parrish JK, Birks DK and
Jedlicka P: The histone demethylase KDM3A, and its downstream
target MCAM, promote Ewing sarcoma cell migration and metastasis.
Oncogene. 36:4150–4160. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Abe Y, Rozqie R, Matsumura Y, Kawamura T,
Nakaki R, Tsurutani Y, Tanimura-Inagaki K, Shiono A, Magoori K,
Nakamura K, et al: JMJD1A is a signal-sensing scaffold that
regulates acute chromatin dynamics via SWI/SNF association for
thermogenesis. Nat Commun. 6:70522015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kuroki S, Matoba S, Akiyoshi M, Matsumura
Y, Miyachi H, Mise N, Abe K, Ogura A, Wilhelm D, Koopman P, et al:
Epigenetic regulation of mouse sex determination by the histone
demethylase Jmjd1a. Science. 341:1106–1109. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Okada Y, Scott G, Ray MK, Mishina Y and
Zhang Y: Histone demethylase JHDM2A is critical for Tnp1 and Prm1
transcription and spermatogenesis. Nature. 450:119–123. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tateishi K, Okada Y, Kallin EM and Zhang
Y: Role of Jhdm2a in regulating metabolic gene expression and
obesity resistance. Nature. 458:757–761. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Inagaki T, Tachibana M, Magoori K, Kudo H,
Tanaka T, Okamura M, Naito M, Kodama T, Shinkai Y and Sakai J:
Obesity and metabolic syndrome in histone demethylase
JHDM2a-deficient mice. Genes Cells. 14:991–1001. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Abe Y, Fujiwara Y, Takahashi H, Matsumura
Y, Sawada T, Jiang S, Nakaki R, Uchida A, Nagao N, Naito M, et al:
Histone demethylase JMJD1A coordinates acute and chronic adaptation
to cold stress via thermogenic phospho-switch. Nat Commun.
9:15662018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Loh YH, Zhang W, Chen X, George J and Ng
HH: Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate
self-renewal in embryonic stem cells. Genes Dev. 21:2545–2557.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ramadoss S, Guo G and Wang CY: Lysine
demethylase KDM3A regulates breast cancer cell invasion and
apoptosis by targeting histone and the non-histone protein p53.
Oncogene. 36:47–59. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ramadoss S, Sen S, Ramachandran I, Roy S,
Chaudhuri G and Farias-Eisner R: Lysine-specific demethylase KDM3A
regulates ovarian cancer stemness and chemoresistance. Oncogene.
36:1537–1545. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Krieg AJ, Rankin EB, Chan D, Razorenova O,
Fernandez S and Giaccia AJ: Regulation of the histone demethylase
JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene
expression and tumor growth. Mol Cell Biol. 30:344–353. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Uemura M, Yamamoto H, Takemasa I, Mimori
K, Hemmi H, Mizushima T, Ikeda M, Sekimoto M, Matsuura N, Doki Y
and Mori M: Jumonji domain containing 1A is a novel prognostic
marker for colorectal cancer: In vivo identification from hypoxic
tumor cells. Clin Cancer Res. 16:4636–4646. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Yu B, Deng P, Cheng Y, Yu Y, Kevork
K, Ramadoss S, Ding X, Li X and Wang CY: KDM3 epigenetically
controls tumorigenic potentials of human colorectal cancer stem
cells through Wnt/β-catenin signalling. Nat Commun. 8:151462017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ,
Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways,
and networks in a collection of 18,000 cancer gene expression
profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Uhlén M, Fagerberg L, Hallström BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the
human proteome. Science. 347:12604192015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim TD, Oh S, Lightfoot SA, Shin S, Wren
JD and Janknecht R: Upregulation of PSMD10 caused by the JMJD2A
histone demethylase. Int J Clin Exp Med. 9:10123–10134.
2016.PubMed/NCBI
|
|
24
|
Kim TD, Oh S, Shin S and Janknecht R:
Regulation of tumor suppressor p53 and HCT116 cell physiology by
histone demethylase JMJD2D/KDM4D. PLoS One. 7:e346182012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mooney SM, Grande JP, Salisbury JL and
Janknecht R: Sumoylation of p68 and p72 RNA helicases affects
protein stability and transactivation potential. Biochemistry.
49:1–10. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dowdy SC, Mariani A and Janknecht R:
HER2/Neu- and TAK1-mediated up-regulation of the transforming
growth factor beta inhibitor Smad7 via the ETS protein ER81. J Biol
Chem. 278:44377–44384. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bosc DG, Goueli BS and Janknecht R:
HER2/Neu-mediated activation of the ETS transcription factor ER81
and its target gene MMP-1. Oncogene. 20:6215–6224. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shin S, Kim TD, Jin F, van Deursen JM,
Dehm SM, Tindall DJ, Grande JP, Munz JM, Vasmatzis G and Janknecht
R: Induction of prostatic intraepithelial neoplasia and modulation
of androgen receptor by ETS variant 1/ETS-related protein 81.
Cancer Res. 69:8102–8110. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Berry WL, Shin S, Lightfoot SA and
Janknecht R: Oncogenic features of the JMJD2A histone demethylase
in breast cancer. Int J Oncol. 41:1701–1706. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Berry WL, Kim TD and Janknecht R:
Stimulation of β-catenin and colon cancer cell growth by the KDM4B
histone demethylase. Int J Oncol. 44:1341–1348. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shin S, Oh S, An S and Janknecht R: ETS
variant 1 regulates matrix metalloproteinase-7 transcription in
LNCaP prostate cancer cells. Oncol Rep. 29:306–314. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim TD, Shin S and Janknecht R: ETS
transcription factor ERG cooperates with histone demethylase KDM4A.
Oncol Rep. 35:3679–3688. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim TD, Shin S, Berry WL, Oh S and
Janknecht R: The JMJD2A demethylase regulates apoptosis and
proliferation in colon cancer cells. J Cell Biochem. 113:1368–1376.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Oh S, Shin S, Lightfoot SA and Janknecht
R: 14-3-3 proteins modulate the ETS transcription factor ETV1 in
prostate cancer. Cancer Res. 73:5110–5119. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shin S, Bosc DG, Ingle JN, Spelsberg TC
and Janknecht R: Rcl is a novel ETV1/ER81 target gene upregulated
in breast tumors. J Cell Biochem. 105:866–874. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim TD, Fuchs JR, Schwartz E, Abdelhamid
D, Etter J, Berry WL, Li C, Ihnat MA, Li PK and Janknecht R:
Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon
cancer cells and identification of curcuminoids as JMJD2
inhibitors. Am J Transl Res. 6:236–247. 2014.PubMed/NCBI
|
|
37
|
Goel A and Janknecht R: Concerted
activation of ETS protein ER81 by p160 coactivators, the
acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu. J
Biol Chem. 279:14909–14916. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Papoutsopoulou S and Janknecht R:
Phosphorylation of ETS transcription factor ER81 in a complex with
its coactivators CREB-binding protein and p300. Mol Cell Biol.
20:7300–7310. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mooney SM, Goel A, D'Assoro AB, Salisbury
JL and Janknecht R: Pleiotropic effects of p300-mediated
acetylation on p68 and p72 RNA helicase. J Biol Chem.
285:30443–30452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu J and Janknecht R: Regulation of the
ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1
and protein kinase A. J Biol Chem. 277:42669–42679. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li X, Moon G, Shin S, Zhang B and
Janknecht R: Cooperation between ETS variant 2 and Jumonji
domain-containing 2 histone demethylases. Mol Med Rep.
17:5518–5527. 2018.PubMed/NCBI
|
|
42
|
Janknecht R: Regulation of the ER81
transcription factor and its coactivators by mitogen- and
stress-activated protein kinase 1 (MSK1). Oncogene. 22:746–755.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kim TD, Jin F, Shin S, Oh S, Lightfoot SA,
Grande JP, Johnson AJ, van Deursen JM, Wren JD and Janknecht R:
Histone demethylase JMJD2A drives prostate tumorigenesis through
transcription factor ETV1. J Clin Invest. 126:706–720. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Oh S and Janknecht R: Histone demethylase
JMJD5 is essential for embryonic development. Biochem Biophys Res
Commun. 420:61–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Goel A and Janknecht R:
Acetylation-mediated transcriptional activation of the ETS protein
ER81 by p300, P/CAF, and HER2/Neu. Mol Cell Biol. 23:6243–6254.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kim TD, Shin S and Janknecht R: Repression
of Smad3 activity by histone demethylase SMCX/JARID1C. Biochem
Biophys Res Commun. 366:563–567. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Janknecht R and Hunter T: Activation of
the Sap-1a transcription factor by the c-Jun N-terminal kinase
(JNK) mitogen-activated protein kinase. J Biol Chem. 272:4219–4224.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Goueli BS and Janknecht R: Regulation of
telomerase reverse transcriptase gene activity by upstream
stimulatory factor. Oncogene. 22:8042–8047. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Goueli BS and Janknecht R: Upregulation of
the catalytic telomerase subunit by the transcription factor ER81
and oncogenic HER2/Neu, Ras, or Raf. Mol Cell Biol. 24:25–35. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kim J, Shin S, Subramaniam M, Bruinsma E,
Kim TD, Hawse JR, Spelsberg TC and Janknecht R: Histone demethylase
JARID1B/KDM5B is a corepressor of TIEG1/KLF10. Biochem Biophys Res
Commun. 401:412–416. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cancer Genome Atlas Natwork: Comprehensive
molecular characterization of human colon and rectal cancer.
Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Smith JJ, Deane NG, Wu F, Merchant NB,
Zhang B, Jiang A, Lu P, Johnson JC, Schmidt C, Bailey CE, et al:
Experimentally derived metastasis gene expression profile predicts
recurrence and death in patients with colon cancer.
Gastroenterology. 138:958–968. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Tsuji S, Midorikawa Y, Takahashi T, Yagi
K, Takayama T, Yoshida K, Sugiyama Y and Aburatani H: Potential
responders to FOLFOX therapy for colorectal cancer by Random
Forests analysis. Br J Cancer. 106:126–132. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ratnakumar K and Bernstein E: ATRX: The
case of a peculiar chromatin remodeler. Epigenetics. 8:3–9. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lin YH, Friederichs J, Black MA, Mages J,
Rosenberg R, Guilford PJ, Phillips V, Thompson-Fawcett M, Kasabov
N, Toro T, et al: Multiple gene expression classifiers from
different array platforms predict poor prognosis of colorectal
cancer. Clin Cancer Res. 13:498–507. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Nakatsuka T, Tateishi K, Kudo Y, Yamamoto
K, Nakagawa H, Fujiwara H, Takahashi R, Miyabayashi K, Asaoka Y,
Tanaka Y, et al: Impact of histone demethylase KDM3A-dependent AP-1
transactivity on hepatotumorigenesis induced by PI3K activation.
Oncogene. 36:6262–6271. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wellmann S, Bettkober M, Zelmer A, Seeger
K, Faigle M, Eltzschig HK and Bührer C: Hypoxia upregulates the
histone demethylase JMJD1A via HIF-1. Biochem Biophys Res Commun.
372:892–897. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Pollard PJ, Loenarz C, Mole DR, McDonough
MA, Gleadle JM, Schofield CJ and Ratcliffe PJ: Regulation of
Jumonji-domain-containing histone demethylases by hypoxia-inducible
factor (HIF)-1alpha. Biochem J. 416:387–394. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Beyer S, Kristensen MM, Jensen KS,
Johansen JV and Staller P: The histone demethylases JMJD1A and
JMJD2B are transcriptional targets of hypoxia-inducible factor HIF.
J Biol Chem. 283:36542–36552. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Mimura I, Nangaku M, Kanki Y, Tsutsumi S,
Inoue T, Kohro T, Yamamoto S, Fujita T, Shimamura T, Suehiro J, et
al: Dynamic change of chromatin conformation in response to hypoxia
enhances the expression of GLUT3 (SLC2A3) by cooperative
interaction of hypoxia-inducible factor 1 and KDM3A. Mol Cell Biol.
32:3018–3032. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wan W, Peng K, Li M, Qin L, Tong Z, Yan J,
Shen B and Yu C: Histone demethylase JMJD1A promotes urinary
bladder cancer progression by enhancing glycolysis through
coactivation of hypoxia inducible factor 1α. Oncogene.
36:3868–3877. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Sar A, Ponjevic D, Nguyen M, Box AH and
Demetrick DJ: Identification and characterization of demethylase
JMJD1A as a gene upregulated in the human cellular response to
hypoxia. Cell Tissue Res. 337:223–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Jones S, Chen WD, Parmigiani G, Diehl F,
Beerenwinkel N, Antal T, Traulsen A, Nowak MA, Siegel C, Velculescu
VE, et al: Comparative lesion sequencing provides insights into
tumor evolution. Proc Natl Acad Sci USA. 105:4283–4288. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Dang CV: MYC on the path to cancer. Cell.
149:22–35. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Rickman DS, Schulte JH and Eilers M: The
expanding world of N-MYC-driven tumors. Cancer Discov. 8:150–163.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Gao J, Yuan S, Jin J, Shi J and Hou Y:
PPARα regulates tumor progression, foe or friend? Eur J Pharmacol.
765:560–564. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Williams C, DiLeo A, Niv Y and Gustafsson
JÅ: Estrogen receptor beta as target for colorectal cancer
prevention. Cancer Lett. 372:48–56. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Juhász S, Elbakry A, Mathes A and Löbrich
M: ATRX promotes DNA repair synthesis and sister chromatid exchange
during homologous recombination. Mol Cell. 71:11–24.e7. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Danussi C, Bose P, Parthasarathy PT,
Silberman PC, Van Arnam JS, Vitucci M, Tang OY, Heguy A, Wang Y,
Chan TA, et al: Atrx inactivation drives disease-defining
phenotypes in glioma cells of origin through global epigenomic
remodeling. Nat Commun. 9:10572018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Garrick D, Sharpe JA, Arkell R, Dobbie L,
Smith AJ, Wood WG, Higgs DR and Gibbons RJ: Loss of Atrx affects
trophoblast development and the pattern of X-inactivation in
extraembryonic tissues. PLoS Genet. 2:e582006. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Gibbons RJ, Picketts DJ, Villard L and
Higgs DR: Mutations in a putative global transcriptional regulator
cause X-linked mental retardation with alpha-thalassemia (ATR-X
syndrome). Cell. 80:837–845. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Dyer MA, Qadeer ZA, Valle-Garcia D and
Bernstein E: ATRX and DAXX: Mechanisms and mutations. Cold Spring
Harb Perspect Med. 7:pii: a0265672017. View Article : Google Scholar
|
|
73
|
Koschmann C, Calinescu AA, Nunez FJ,
Mackay A, Fazal-Salom J, Thomas D, Mendez F, Kamran N, Dzaman M,
Mulpuri L, et al: ATRX loss promotes tumor growth and impairs
nonhomologous end joining DNA repair in glioma. Sci Transl Med.
8:328ra282016. View Article : Google Scholar : PubMed/NCBI
|
